Long-lasting residual efficacy of a new indoor residual spraying product, VECTRON™ T500 (broflanilide), against pyrethroid-resistant malaria vectors and its acceptance in a community trial in Burkina Faso
The residual efficacy of VECTRON<sup>™</sup> T500 extended for 12 months post-spraying, effectively covering the full malaria transmission season while maintaining high mortality rates in pyrethroid-resistant malaria vectors. VECTRON<sup>™</sup> T500 demonstrated non-inferiority in performance compared to Actellic<sup>®</sup> 300CS, the standard reference product. This new IRS formulation has the potential to play a crucial role in managing insecticide resistance by being integrated into a rotational strategy alongside other IRS products containing insecticides with different modes of action.
Authors
- Aristide S. Hien (ORCID: https://orcid.org/0000-0001-6649-6676)
- Samina Maiga
- Welbeck A. Oumbouke (ORCID: https://orcid.org/0000-0002-7254-7860)
- Jean Birba
- Abdoulaye Diabaté (ORCID: https://orcid.org/0000-0002-9666-9395)
- Roch K. Dabiré (ORCID: https://orcid.org/0000-0002-3471-3506)
- Dieudonné Diloma Soma (ORCID: https://orcid.org/0000-0001-8294-9110)
- Marlize Coleman
- Graham Small
- Koama Bayili (ORCID: https://orcid.org/0000-0003-2670-4543)
- Janneke Snetselaar (ORCID: https://orcid.org/0000-0002-5882-6855)
- Sidzabda Kompaoré
- Delphine Ouissamien Karama
- Shinya Niimi
- Kawase Ayumi
- Adissa Y. Ouattara
- Katsutoshi Tsuchiya
Institutions
- Centre National de la Recherche Scientifique et Technologique (BF)
- Innovative Vector Control Consortium (GB)
- MalariaGEN (BF)
- Mitsui Chemicals (Japan) (JP)
Publication Details
- Journal
- Parasites & Vectors
- Published
- 2024-11-23
- DOI
- https://doi.org/10.1186/s13071-024-06577-y
- Citations
- 3
- Primary Topic
- Malaria Research and Control
- Type
- article
- Field-Weighted Citation Impact
- 1.63